Correlation Between Basilea Pharmaceutica and Dow Jones
Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Dow Jones at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Dow Jones into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Basilea Pharmaceutica AG and Dow Jones Industrial, you can compare the effects of market volatilities on Basilea Pharmaceutica and Dow Jones and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Dow Jones. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Dow Jones.
Diversification Opportunities for Basilea Pharmaceutica and Dow Jones
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Basilea and Dow is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Dow Jones Industrial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dow Jones Industrial and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Dow Jones. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dow Jones Industrial has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Dow Jones go up and down completely randomly.
Pair Corralation between Basilea Pharmaceutica and Dow Jones
Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to under-perform the Dow Jones. In addition to that, Basilea Pharmaceutica is 1.11 times more volatile than Dow Jones Industrial. It trades about -0.27 of its total potential returns per unit of risk. Dow Jones Industrial is currently generating about 0.21 per unit of volatility. If you would invest 4,237,436 in Dow Jones Industrial on August 25, 2024 and sell it today you would earn a total of 192,215 from holding Dow Jones Industrial or generate 4.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 95.65% |
Values | Daily Returns |
Basilea Pharmaceutica AG vs. Dow Jones Industrial
Performance |
Timeline |
Basilea Pharmaceutica and Dow Jones Volatility Contrast
Predicted Return Density |
Returns |
Basilea Pharmaceutica AG
Pair trading matchups for Basilea Pharmaceutica
Dow Jones Industrial
Pair trading matchups for Dow Jones
Pair Trading with Basilea Pharmaceutica and Dow Jones
The main advantage of trading using opposite Basilea Pharmaceutica and Dow Jones positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Dow Jones can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dow Jones will offset losses from the drop in Dow Jones' long position.Basilea Pharmaceutica vs. Santhera Pharmaceuticals Holding | Basilea Pharmaceutica vs. Idorsia | Basilea Pharmaceutica vs. Molecular Partners AG | Basilea Pharmaceutica vs. Evolva Holding SA |
Dow Jones vs. Vistra Energy Corp | Dow Jones vs. Fluence Energy | Dow Jones vs. Old Republic International | Dow Jones vs. Empresa Distribuidora y |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |